Trial Profile
Comparing early vs late initiation of oseltamivir in hospitalised patients with documented 2009 inuenza A/H1N1: retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2017
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Therapeutic Use
- 29 Jun 2017 New trial record
- 05 Jun 2017 Results presented at the ASM Microbe 2017